Elzanor Txr 25/5/1000mg (14 Tablets / Pack)
Triple combination tablet that helps control blood sugar in type 2 diabetes.
- Category
- Tablets & Capsules
This combination tablet contains empagliflozin, linagliptin, and metformin, three medicines that work together to control blood sugar in type 2 diabetes. Empagliflozin promotes glucose loss through urine, linagliptin boosts insulin release after meals, and metformin reduces glucose production by the liver and improves insulin sensitivity. It is used when diet, exercise, and simpler regimens are insufficient. It is usually taken with meals to reduce stomach upset.
Purpose
Combination therapy to control blood sugar in adults with type 2 diabetes.
Ingredients
Empagliflozin 25mg + Linagliptin 5mg + Metformin Hydrochloride 1000mg
Warnings
Not for use in type 1 diabetes or diabetic ketoacidosis | Avoid in patients with significant kidney or liver impairment | May increase risk of urinary tract and genital infections | Stop before contrast imaging procedures as advised by your doctor | Not recommended during pregnancy or breastfeeding
Side Effects
Urinary tract infections | Genital yeast infections | Nausea or stomach upset | Diarrhea | Low blood sugar when combined with other diabetes medicines
Storage Instructions
Store below 30°C in a dry place, away from direct sunlight, out of reach of children.
| Brand | General |
|---|---|
| Status | Active |